Trial Profile
Dose Ranging Trial for the Evaluation of the Safety and Efficacy of GW813893 in the Prophylaxis of Venous Thromboembolism Post Total Knee Replacement Surgery.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs 813893 (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 11 Apr 2013 New trial record